Reloading patients chronically treated with P2Y12 inhibitors and presenting with ACS/PCI: Facing a crossroad? - International Journal of Cardiology
PDF) Prehospital administration of P2Y12 inhibitors and early coronary reperfusion in primary PCI: An observational comparative study
Poll Results: Preload With P2Y12 Inhibitor - American College of Cardiology
INCIDENCE AND RATIONALE FOR P2Y12 INHIBITOR SWITCHING IN PATIENTS WITHIN 1 YEAR OF PERCUTANEOUS CORONARY INTERVENTION - Canadian Journal of Cardiology
Multivessel Versus Culprit-only Percutaneous Coronary Intervention in ST-segment Elevation Acute Myocardial Infarction: Analysis of an 8-year Registry | Revista Española de Cardiología (English Edition)
Comparison of Dabigatran Plus a P2Y12 Inhibitor With Warfarin-Based Triple Therapy Across Body Mass Index in RE-DUAL PCI - The American Journal of Medicine
Meta-Analysis of the Efficacy and Safety of Genotype-Guided Strategy for Selection of P2Y12 Inhibitors in Coronary Artery Disease - American Journal of Cardiology
Antithrombotic therapy for patients with STEMI undergoing primary PCI | Nature Reviews Cardiology
stemi
One-year clinical outcomes of ticagrelor compared with clopidogrel after percutaneous coronary intervention in patients with acute myocardial infarction: From Korean Health Insurance Review and Assessment Data - Journal of Cardiology
Optimal pharmacological therapy in ST-elevation myocardial infarction—a review | SpringerLink
JCM | Free Full-Text | P2Y12 Inhibitor Monotherapy with Clopidogrel versus Ticagrelor in Patients with Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention | HTML
Randomized comparison of new dual-antiplatelet therapy (aspirin, prasugrel) and triple-antiplatelet therapy (aspirin, clopidogrel, cilostazol) using P2Y12 point-of-care assay in patients with STEMI undergoing primary PCI - International Journal of ...
Effect of P2Y12 Inhibitor Monotherapy vs Dual Antiplatelet Therapy on Cardiovascular Events in Patients Undergoing Percutaneous Coronary Intervention: The SMART-CHOICE Randomized Clinical Trial.,JAMA - X-MOL
A pharmacodynamic comparison of 5 anti-platelet protocols in patients with ST-elevation myocardial infarction undergoing primary PCI – topic of research paper in Clinical medicine. Download scholarly article PDF and read for free
P2Y12 inhibitors during and after acute coronary syndrome, where do we stand in 2020?
Management of patients after primary percutaneous coronary intervention for myocardial infarction | The BMJ
Myo.infarction
Current guideline recommendations on P2Y 12 receptor directed treatment... | Download Table
60221-2.fp.png "P2Y12 RECEPTOR INHIBITION ACCORDING TO PREHOSPITAL ADMINISTRATION OF TICAGRELOR IN PRIMARY PCI FOR ST ELEVATION MYOCARDIAL INFARCTION: THE PRIVATE-ATLANTIC STUDY | Journal of the American College of Cardiology")
P2Y12 RECEPTOR INHIBITION ACCORDING TO PREHOSPITAL ADMINISTRATION OF TICAGRELOR IN PRIMARY PCI FOR ST ELEVATION MYOCARDIAL INFARCTION: THE PRIVATE-ATLANTIC STUDY | Journal of the American College of Cardiology
PDF) Contemporary use of P2Y12 inhibitors in patients with ST-segment elevation myocardial infarction referred to primary percutaneous coronary interventions in Poland: Data from ORPKI national registry
